where is cryptocurrency used snippets

Hongrun Construction established a commercial management company in Wuxi. According to the enterprise search APP, Wuxi Hongrun Commercial Management Co., Ltd. was recently established. The legal representative is Jin Zhenjun, with a registered capital of 1 million yuan. Its business scope includes: commercial complex management services; Property management; Real estate broker, etc. Enterprise investigation shows that the company is wholly owned by Hongrun Construction.The first-phase factory construction project of Aidi Precision (Thailand) started. According to Aidi Precision, in order to better lay out the global market, on December 12, Aidi Precision's first overseas manufacturing factory, Aidi Precision (Thailand), officially started construction. The construction project of Aidi Precision (Thailand) Factory, with a total investment of 35 million US dollars, covers an area of 122 mu and a workshop area of about 60,000 square meters. It will be engaged in the production, manufacture and sales of high-end hydraulic components and hydraulic fittings for construction machinery. The first phase of the project is scheduled to be completed and put into operation in October 2025.Domestic futures fell more and rose less, No.20 rubber fell nearly 3%, domestic futures fell more and rose less, No.20 rubber fell nearly 3%, Shanghai Bank and BR rubber fell nearly 2%, and rubber, caustic soda, vegetable oil, rapeseed meal, hot coil, international copper and pulp fell more than 1%. In terms of increase, Shanghai nickel and alumina rose by over 1%, while SC crude oil and palm oil rose by nearly 1%.

The retail sector continued its upward trend of Zhongbai Group for 10 days and 7 boards, and the retail sector continued its upward trend. Zhongbai Group for 10 days and 7 boards, Maoye Commercial and Actually Zhijia had daily limit, and Guangbai shares, Dashang shares, Central Shopping Mall and Hongqi Chain opened higher collectively.Real estate stocks fluctuated lower, with Gorgeous Family, Qixia Construction, Everbright Jiabao and Tiandiyuan falling more than 5%, while urban construction development and Chongqing development followed suit.The United States ITC officially launched a 337 investigation on injection molding machines, their components and downstream products. According to China Trade Relief Information Network, on December 12, the United States International Trade Commission (ITC) voted to launch a 337 investigation (investigation code: 337-TA-1427) on specific injection molding machines, their components and downstream products.

According to the International Monetary Fund, the completion of the second project review will provide Jordan with about $131 million.Pengyue Automobile Development Co., Ltd., a subsidiary of Tucki, was forced to enforce 680,000 yuan. According to the risk information of Tianyan, recently, Guangzhou Pengyue Automobile Development Co., Ltd. and Hunan Chunqiu Engineering Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 684,000 yuan, involving construction contract disputes. The enforcement court is Tianhe District People's Court of Guangzhou. Guangzhou Pengyue Automobile Development Co., Ltd. was established in August 2021, with the legal representative of Zhao Dawu and the registered capital of 1.88 billion RMB. Its business scope includes auto parts retail, tire sales, investment activities with its own funds, electric vehicle charging infrastructure operation, industrial design service and motor vehicle charging sales, etc. It is wholly owned by Guangzhou Xpeng Motors Technology Co., Ltd.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.